Frequently asked questions by pharma product sellers

Frequently asked questions

For buyers

For sellers

Pipelinepharma provides asset developers and manufacturers with a direct, commission-free B2B route to global buyers, alongside advanced tools to optimize your out-licensing strategy:

Global B2B Market Exposure: Free registration allows you to list an unlimited number of generics, biosimilars, medical devices, or nutraceuticals, making your portfolio instantly visible to verified global buyers. Furthermore, you receive incoming business inquiries for your products completely free of charge. If a buyer submits a request and you confirm mutual interest, we introduce you directly to the buyer for independent negotiations with no commission or success fees.
Targeted Product Positioning: Every product card includes a free-text section where you can specify important details, such as "Looking for a partner for co-development" or "Looking for a CMO," helping you connect with the right partner faster.
Smart Data-Driven Pricing & Strategy: Upgrading to a paid subscription grants you access to our Generic and Biosimilar Pipeline Intelligence. This allows your team to audit hidden, pre-launch dossier density globally to model Day-1/First-Year competition post-LOE, de-risk new generic R&D projects, or forecast innovator price erosion. (For a deeper breakdown of these capabilities, see: "What does a Subscription offer to Sellers and product IP owners?")
Custom Market Research: For deeper local insights, our analysts offer a specialized Market research Service covering pricing and regulatory competition across 70+ countries worldwide.

Pipelinepharma is the pioneer of Generic and Biosimilar Pipeline Intelligence (Pillar 2). While traditional market databases rely on retrospective sales data or public clinical trials (Pillar 1), we focus on the hidden, pre-launch Common Technical Document (CTD) dossier layer. Having the largest CTD database, our platform tracks the readiness, velocity, and volume of upcoming generic files globally, allowing pharma leaders to eliminate strategic blind spots, protect capital investments, and accurately forecast Day-1 commercial competition.

For dossier developers and FDF manufacturers, our Generic and Biosimilar Pipeline Intelligence serves as a critical strategic tool to optimize your out-licensing margins and validate your R&D pipeline before committing capital to asset development:

Out-Licensing Pricing Optimization: Look behind the scenes to see how many competing, hidden developers hold equivalent ready-to-file dossiers for your target molecule. Understanding this upstream density allows your business development team to set realistic, competitive supply prices and defend your existing client accounts before they look for alternative suppliers.
Day-1 Launch, LOE & Price Erosion Forecasting: Map out the exact volume, readiness timelines, and regulatory speed of hidden generic files preparing behind patent walls. For originator companies, this data serves as the foundation to mathematically forecast post-patent price erosion, change strategic timing decisions, and initiate timely product diversification or line extensions before the legacy asset's margins collapse. For generic developers, it accurately helps forecast realistic market share.
Pre-Development Risk Assessment: Before committing heavy R&D or clinical manufacturing budgets to a new generic project, stress-test its global file readiness. Identifying an incoming wave of hidden files early allows you to redirect your manufacturing capacity toward more profitable, low-competition therapeutic spaces.

Beyond generating high-quality inbound leads, our platform gives you full visibility into the competitive landscape of CTD dossiers across your target molecules. Understanding how many other manufacturers are developing the same formulation allows you to benchmark your dossier’s value, optimize your licensing fees, and approach buyers in regions where competition is still low.

Pipelinepharma operates on a strict double-blind anonymity model to protect your business interests. We only display high-level product characteristics (e.g., active substances, dosage, formulation, CTD type like EU/US CTD, and GMP certifications like EU GMP or FDA GMP). Your company name and identity remain completely anonymous on the platform. Buyers can see the product profiles, technical parameters, and restricted/available markets (which updates trust in your dossier's quality), but they cannot see who the IP holder is. Your identity and contact details are only disclosed to an interested buyer after you manually review and approve their connection request. Until that confirmation, both parties remain invisible to each other.

Original product innovators use our platform to defend their market share. By tracking the volume, velocity, and readiness of upcoming generic and biosimilar eCTD dossiers behind the patent wall, innovators can precisely predict when their revenue margins will face generic competition and proactively adjust their lifecycle management strategies. More information here

Upgrading to a paid subscription grants you access to our Generic and Biosimilar Pipeline Intelligence to eliminate market blind spots. This data allows your team to audit hidden pre-launch dossier density globally, giving you critical leverage across three strategic areas:

For Generic Out-Licensing: Accurately evaluate future competition to set competitive supply prices, project Day-1/First-Year launch density post-LOE, and proactively defend your current commercial accounts.
For R&D Planning: Stress-test the viability of new generic development projects before committing capital, avoiding over-saturated molecule waves.
For Innovators: Quantify the exact volume of incoming generic files to mathematically model price erosion and execute precise lifecycle defense strategies.

Pipelinepharma operates as a direct B2B sourcing network and does not act as a traditional broker. There are no commissions or success fees for sellers when a buyer submits a request through the platform and both parties confirm their interest in starting direct discussions. This incoming inquiry model is completely free for sellers.

Paid services are available depending on your commercial objectives:

Annual Paid Subscription: Grants your team full access to our Generic and Biosimilar Pipeline Intelligence data to audit hidden pre-launch file density, evaluate Day-1 competition post-LOE, and optimize your out-licensing supply prices.
Premium Partner Search: A proactive, fee-based service where our team conducts custom market assessments and runs targeted outreach campaigns to find and secure qualified buyers for your portfolio.

Reach out to our Sales team to learn more about how Premium Partner Search or Subscription works and its pricing.

It's free to sign up and list an unlimited number of your products on Pipelinepharma. Here's how it works:

You sign up and add your products by filling in the information about the formulation, regulatory availability and production data. You can add as many products as you want
We double-check the details and contact you or(and) approve your product entry within 48 hours
You get access to your dashboard
You can manage (add, delete, update) your product information anytime you need it in the dashboard.

Important: If you have signed up and registered your products, but haven’t heard from us within 48 hours, don’t worry — we’re still reviewing your information and will be in touch shortly.

Don't have time? You can send your product list to us by email [email protected] and our team will upload your products for you.

If you are a dossier owner and(or) manufacturer of finished dosage formulations (FDF), who seeks to enter into licensing, distribution or another type of partnering agreement, you are welcome to list your products on the Pipelinepharma marketplace.

It's free to sign up and add an unlimited number of your products: generics, biosimilars, medical devices or nutraceuticals.

You can list your products for any peaceful market worldwide by registering directly on the platform or by sending your product list to us by email at [email protected] so we can upload your products for you.

Additionally, every product card includes a free-text section where you can specify important details, such as "Looking for a partner for co-development" or "Looking for a CMO." This functionality helps streamline your search for specific partners based on your project criteria.

For pharmaceuticals, we ask you to specify basic product and regulatory information: the generic name (INN), dosage form, strength, shelf life, dossier status, dossier type, and manufacturing site approvals (GMP). You should also indicate your preferred partnership type (licensing, distribution, tech-transfer, or co-development).

To attract buyers faster and achieve shorter matching timelines, it is highly recommended to list any existing Marketing Authorizations (MAs) for sale and the specific countries where the product is already registered. This data allows buyers to instantly evaluate the fastest regulatory pathway for their target markets.

We ask you to specify core commercial parameters: your Minimum Order Quantity (MOQ) or batch size, and a list of unavailable markets. This helps us filter out inquiries that do not match your criteria, protecting both sides from sharing sensitive information unnecessarily. Providing these details upfront manages buyer expectations regarding feasibility and helps streamline the transition toward a term sheet.

Yes. Once your products are registered, you can update their technical and commercial details at any time. You can add or delete products, change development status, edit GMP approvals, update stability or clinical data, and adjust your minimum order quantity (MOQ) or market availability. Furthermore, you can use the free-text section to add specific project details or clear outdated messages from your listings.

Your products will be published online within 48 hours after registering them on Pipelinepharma if the entry details pass our internal checks. We will send you an email once your entry details are confirmed. You can also check the approval status in your dashboard anytime.

Incoming RFQs typically include a 2-to-3-year annual purchase volume forecast, the target market, and the local market price level. These parameters give you the required data to evaluate the viability of the business case.

To proceed, your first step is to confirm whether the business case interests you and whether you agree to be directly introduced to the buying company.

If you prefer not to disclose your identity immediately or spend time on early-stage discussions, you can simply reply to the notification email with a preliminary price and commercial offer anonymously through the platform. The direct introduction and handover for direct negotiations will only take place once the buying company reviews your proposal and broadly agrees with the core preliminary terms offered.

While standard market risk always exists, Pipelinepharma uses a multi-layered verification system to filter out casual inquiries:

Paid Subscription Barrier: Inquiries are restricted to paid subscribers. The commitment to an annual fee automatically deters non-serious market actors.
Pre-Onboarding Evaluation: Before a company can subscribe, our team meets with them multiple times to verify and evaluate their actual sourcing needs.
Strict Company Qualification: We vet registering buyers to ensure only legitimate, verified pharmaceutical companies can submit requests.
Manufacturer Feedback Loop: We track supplier feedback. If a buyer receives multiple negative reviews from different manufacturers, we investigate and block their account from sending further requests.

You can upgrade your account to a paid subscription to access our global CTD dossier database and Generic and Biosimilar Pipeline Intelligence. This allows you to evaluate the upstream competitive landscape and adjust your pricing to better match current market realities.

Alternatively, our Research team can perform customized market research using our network and industry databases to investigate pricing for specific products across more than 70 countries. This data assists you in structuring competitive commercial offers that align with target markets.

To check current product pricing in a specific country, read more about our Market Research service here.

You can indicate your priority products and commercial offers for your target markets. The Pipelinepharma Sales and Marketing team will then actively promote these products to our network of qualified buyers. Usually, you get the first feedback from the market within 30 business days. If the offer is competitive and attractive, your company can soon sign a commercial term sheet with the buyer.

The Active promotion service is provided for a fixed fee, agreed upon by Pipelinepharma and the manufacturer on a case-by-case basis. Please contact our Sales team for more information.

Our Premium Partner Search is a proactive, data-driven service designed to find the right commercial match for your product in a specific target market. The service follows a structured three-step process:

Market Opportunity & Business Case Assessment
Before launching a campaign, our team conducts a market analysis for your target molecule and country. We map out active market competitors, track hidden pre-launch file density using our Generic Pipeline Intelligence data, and evaluate pricing potential—including reimbursement status. We deliver this risk and opportunity assessment to you upfront so both sides have a clear overview of the market's feasibility.
Targeted Campaigns & Qualified Lead Sourcing
Based on your criteria, we build a tailored list of compliant pharmaceutical companies operating in that target region. Our team manages an active outreach campaign to pitch your business case directly to these companies. We collect all marketplace feedback and share both positive interest and negative responses (client voice) with you in real-time.
Direct Introductions & Connection Handover
Once the campaign yields qualified buyers who confirm direct commercial interest, we provide you with a list of verified company profiles and contact details. We make the formal introduction between both parties, allowing you to take over the direct negotiations and close the agreement independently.

Frequently asked questions

Want to get industry news?